Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Cocaine Abuse and ADHD
NCT00000275Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Nov 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence and attention deficit hyperactivity disorder (ADHD) comparing Bupropion with Placebo (2 arms). Primary endpoints: Side effects, Drug use and 4 more. Started Nov 1996; status: completed.
02
Drugs
bupropion
03
Conditions
cocaine dependenceattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00000275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000275.